Childhood cancer: a comparative analysis of incidence, mortality, and survival in Goiania (Brazil) and other countries

Cadernos de saúde pública
Patrícia Emília BragaMaria Paula Curado

Abstract

Analysis of cancer incidence, mortality, and survival rates can yield geographic and temporal trends that are useful for planning and evaluating health interventions. This article reviews cancer incidence and mortality rates and respective trends around the world in children under 15 years old, as well as their 5-year survival rates in developed and developing countries. We conclude that even though increasing or stable childhood cancer incidence rates and decreasing mortality rates have been observed in developed countries, the trends remain unknown in developing countries. Data from the city of Goiania, Brazil, show stable childhood cancer incidence and mortality rates. Five-year survival rates (48%) in Goiania are similar to those seen in underdeveloped regions and lower than those reported in developed countries (64-70%).

Associated Clinical Trials

References

Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LeviP Boyle
Mar 18, 1992·Journal of the National Cancer Institute·M DesmeulesY Mao
Oct 15, 1991·Cancer·S Krishnamurthy, M Dhar
Nov 1, 1990·CA: a Cancer Journal for Clinicians·W A Bleyer
Nov 1, 1990·British Journal of Cancer·C A Stiller, K J Bunch
Sep 1, 1989·International Journal of Epidemiology·P de Nully BrownO M Jensen
Oct 15, 1988·International Journal of Cancer. Journal International Du Cancer·D M ParkinC A Bieber
Jan 1, 1985·Epidemiologic Reviews·R S Greenberg, J L Shuster
Dec 15, 1983·International Journal of Cancer. Journal International Du Cancer·N E Breslow, B Langholz
Apr 1, 1984·British Journal of Cancer·W R McWhirter, V Siskind
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LeviP Boyle
Jun 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P KaatschJ Michaelis
Jan 1, 1994·Medical and Pediatric Oncology·B Novakovic
Jan 1, 1995·Cancer·R W MillerB Novakovic
Jul 16, 1994·BMJ : British Medical Journal·C M RobertsonJ E Kingston
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M C Martos, J H Olsen
Jan 3, 1996·International Journal of Cancer. Journal International Du Cancer·W R McWhirterI Ring
Mar 1, 1996·International Journal of Cancer. Journal International Du Cancer·E KramarovaA Obsitnikova
Jun 8, 1996·Lancet·C La VecchiaA Decarli
Aug 1, 1996·Cancer·J G GurneyL L Robison
Sep 1, 1996·Medical and Pediatric Oncology·G Wessels, P B Hesseling
Jan 1, 1996·Paediatric and Perinatal Epidemiology·S SriampornJ Ferlay
Jul 1, 1996·Cancer Causes & Control : CCC·A NandakumarM Dhar
Dec 11, 1995·International Journal of Cancer. Journal International Du Cancer·G GilesH Farrugia
Apr 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M PollánN Aragonés
Nov 5, 1997·Journal of Pediatric Hematology/oncology·J G GurneyL L Robison
Aug 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W A Bleyer
Jan 10, 1998·Environmental Health Perspectives·C W Schmidt
Sep 10, 1998·Journal of the National Cancer Institute·W C Black
Sep 10, 1998·Journal of the National Cancer Institute·M A SmithR Simon
Jun 24, 1999·Journal of the National Cancer Institute·M S LinetS S Devesa
Oct 2, 2001·CA: a Cancer Journal for Clinicians·R T GreenleeM Thun

❮ Previous
Next ❯

Citations

May 9, 2019·Ciência & saúde coletiva·Isadora Marques BarbosaRaquel Maria Rigotto
Aug 5, 2010·Ciência & saúde coletiva·Aline May BarbosaAngela Scarparo Caldo-Teixeira
Oct 8, 2016·BMC Oral Health·Deise Berger VeltenMaria Helena Monteiro de Barros Miotto
Dec 22, 2016·Pediatric Blood & Cancer·Mecneide Mendes LinsBeatriz de Camargo
Aug 21, 2020·Cancer Epidemiology·Max Moura de OliveiraMaria Paula Curado

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Edesio MartinsRuffo Freitas
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
N R S ReisR M B Martins
© 2022 Meta ULC. All rights reserved